Neurocompute scores pediatric oncology literature, surfaces overlooked therapeutic signals, and turns fragmented childhood cancer research into a living discovery terminal.
A grade PMID 42321916
View analysis →A grade PMID 42690647
View analysis →A grade PMID 42372741
View analysis →A grade PMID 42216567
View analysis →A grade PMID 41916649
View analysis →A grade PMID 42382416
View analysis →A grade PMID 42150584
View analysis →B grade PMID 42748428
View analysis →A grade PMID 41756844
View analysis →A grade PMID 42765973
View analysis →A grade PMID 42362103
View analysis →A grade PMID 42101908
View analysis →In a Japanese claims-based cohort, pediatric tracheostomy was most frequent in infancy, with 5-year cumulative incidences of 40.6% for decannulation and 22.2% for death, and malignancy was associated with earlier death.
The record provides observational evidence that malignancy identifies children at higher risk of death after tracheostomy; it may therefore support investigation of oncology-specific risk stratification, counseling, and coordinated airway and palliative-support planning, but it does not show that any intervention improves survival or decannulation.
This record summarizes neuroblastoma's variable clinical risk, common adrenal origin, risk-adapted treatment, and the role of surgical resection in local control.
The supplied abstract supports risk-based treatment intensity and surgery as established management concepts; it can only be inferred, not demonstrated here, that further refinement of risk selection or surgical strategy could improve outcomes or reduce treatment burden.
This single-center retrospective study found that, during COVID-19 restrictions, fewer evaluated women with adnexal masses underwent surgery and the selected surgical cohort was older and enriched for higher ADNEX scores and non-benign histology compared with the pre-pandemic cohort.
Evidence: pandemic-era surgical selection was associated with greater sonographic risk and more non-benign pathology among operated patients. Inference: structured ultrasound risk models might help prioritize adnexal-mass surgery when access is constrained, but this study does not establish treatment benefit, safety of deferral, or applicability to pediatric patients.
This case report and focused review describes an infant with mandibular metastatic, MYCN-amplified neuroblastoma and summarizes 31 published pediatric cases, emphasizing that atypical mandibular swelling may warrant imaging, biopsy, and oncology referral.
The supplied evidence supports mandibular involvement as a rare clinical presentation of metastatic neuroblastoma; it can be inferred that earlier recognition may reduce diagnostic delay, but the record does not demonstrate that any specific treatment—including lorlatinib—improves outcomes in this setting.
This nationally representative cross-sectional analysis of 15,254 Tanzanian women aged 15–49 reports low cervical cancer screening uptake and associations with age, education, occupation, recent healthcare use, contraceptive use, HIV status, and residence.
The evidence identifies population groups and healthcare-access factors associated with screening uptake; it can be inferred—but is not tested here—that targeted outreach, health-literacy, and access interventions might increase screening, particularly among younger, less educated, rural, and socioeconomically disadvantaged women.
In a retrospective health-system cohort of 385,419 women aged 18–74, non-Hispanic Black women had a statistically shorter interval between their pre-pandemic and pandemic mammograms than non-Hispanic White women.
The study provides evidence of a racial difference in mammography timing during COVID-19, but it does not test a treatment or screening intervention; any hypothesis that identifying the health-system factors underlying this pattern could improve equitable screening continuity is inferential.
This qualitative interview study of women diagnosed with breast cancer before age 40 reports common symptomatic and delayed diagnoses alongside age-specific emotional, family, and fertility concerns.
The study provides no evidence for a cancer therapy; it supports the inference that age-tailored awareness, diagnostic pathways, and supportive or fertility care could reduce delays and improve care experiences, but these strategies were not tested.
In a national observational sample of 18,678 veterans with cancer, women, adults aged 18–44 years, and lower-income participants disproportionately reported barriers to healthcare access and utilization.
The evidence identifies demographic and socioeconomic groups with greater access barriers; it may support testing targeted navigation, financial assistance, transportation, or caregiving-support interventions, but the record does not evaluate any intervention or demonstrate improved cancer outcomes.
This hospital-based questionnaire case-control study found that firstborn status, but not low birth weight below 2500 g, was independently associated with infantile hemangioma among Japanese children and dermatological controls.
Evidence: firstborn status showed a modest adjusted association with infantile hemangioma (aOR 1.82, 95% CI 1.03–3.20), whereas categorical low birth weight did not; inference: investigating biological or healthcare-related factors correlated with birth order might generate etiologic or risk-stratification hypotheses, but this record provides no therapeutic target, intervention, or causal mechanism.
This 10-year population-based hospitalization study reports disease- and age-specific admission patterns and higher mortality, ICU use, length of stay, and readmission among people with six rare bone diseases compared with matched general-population hospitalizations.
The evidence identifies elevated hospital burden and a reported malignancy frequency of 22.7% among patients with X-linked hypophosphatemia; it is an untested inference that validated risk stratification, tailored surveillance, or coordinated long-term care could improve outcomes, and the record does not establish an oncology intervention or causal cancer association.
This review describes age- and imaging-based differential diagnosis of pediatric supratentorial tumors, including high- versus low-grade, intraventricular, and rare lesions, and notes that some entities have diagnosis- and prognosis-defining genetic alterations.
The supplied record supports imaging-based diagnostic narrowing and recognition of molecularly defined tumor entities; it is reasonable to infer that more accurate classification could improve surgical and adjuvant-treatment selection, but no therapeutic intervention or outcome benefit is evaluated.
This protocol describes a 14-patient prospective observational comparison of unilateral Le Fort I advancement and dentoalveolar transport distraction for large unilateral alveolar clefts, with recruitment ongoing and no outcome data yet reported.
The record establishes only that two graftless surgical approaches will be compared; it is hypothesized, but not yet demonstrated, that one may offer better gap closure, arch form, segment stability, or wound healing while avoiding donor-site morbidity.
